Bayer reports advance in Monsanto takeover negotiations
The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG.
"Last attempt"
“We see the current price offered as a last attempt to arrange for a negotiated transaction,” Peter Spengler, an analyst at DZ Bank AG, said in a note to clients. Bayer’s management team is likely to ask the supervisory board for approval for a hostile takeover when it meets next week, he wrote, and forecast that a deal would likely be completed at $130-$135 a share, Bloomberg reports.
For more information:
www.advancingtogether.com